Sector 10, Inc. (SECI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 9.84 Million USD | -0.06% |
| 2022 | 9.85 Million USD | -5.06% |
| 2021 | 10.37 Million USD | -16.29% |
| 2020 | 12.39 Million USD | 12.31% |
| 2019 | 11.03 Million USD | 13.41% |
| 2018 | 9.73 Million USD | 14.35% |
| 2017 | 8.51 Million USD | 16.72% |
| 2016 | 7.29 Million USD | 18.48% |
| 2015 | 6.15 Million USD | 20.71% |
| 2014 | 5.09 Million USD | 24.33% |
| 2013 | 4.1 Million USD | 29.54% |
| 2012 | 3.16 Million USD | 32.73% |
| 2011 | 2.38 Million USD | 25.57% |
| 2010 | 1.89 Million USD | 109.08% |
| 2009 | 908.4 Thousand USD | 7.46% |
| 2008 | 845.37 Thousand USD | -47.36% |
| 2007 | 1.6 Million USD | -16.13% |
| 2006 | 1.91 Million USD | -6.92% |
| 2005 | 2.05 Million USD | 252.01% |
| 2004 | 584.39 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 9.86 Million USD | 0.07% |
| 2024 Q2 | 9.85 Million USD | 0.05% |
| 2024 Q1 | 9.85 Million USD | 0.05% |
| 2023 Q1 | 9.85 Million USD | 0.05% |
| 2023 Q4 | 9.84 Million USD | 0.39% |
| 2023 Q2 | 9.86 Million USD | 0.06% |
| 2023 FY | 9.84 Million USD | -0.06% |
| 2023 Q3 | 9.8 Million USD | -0.56% |
| 2022 Q1 | 10.39 Million USD | 0.18% |
| 2022 Q2 | 9.83 Million USD | -5.43% |
| 2022 Q3 | 9.84 Million USD | 0.11% |
| 2022 FY | 9.85 Million USD | -5.06% |
| 2022 Q4 | 9.85 Million USD | 0.11% |
| 2021 Q3 | 10.62 Million USD | -14.75% |
| 2021 Q4 | 10.37 Million USD | -2.37% |
| 2021 FY | 10.37 Million USD | -16.29% |
| 2021 Q1 | 12.74 Million USD | 2.82% |
| 2021 Q2 | 12.46 Million USD | -2.19% |
| 2020 Q4 | 12.39 Million USD | 3.05% |
| 2020 Q1 | 11.37 Million USD | 3.03% |
| 2020 Q2 | 11.69 Million USD | 2.85% |
| 2020 Q3 | 12.02 Million USD | 2.84% |
| 2020 FY | 12.39 Million USD | 12.31% |
| 2019 Q3 | 10.7 Million USD | 3.16% |
| 2019 FY | 11.03 Million USD | 13.41% |
| 2019 Q2 | 10.37 Million USD | 3.24% |
| 2019 Q4 | 11.03 Million USD | 3.1% |
| 2019 Q1 | 10.05 Million USD | 3.28% |
| 2018 Q4 | 9.73 Million USD | 3.35% |
| 2018 FY | 9.73 Million USD | 14.35% |
| 2018 Q3 | 9.41 Million USD | 3.34% |
| 2018 Q2 | 9.11 Million USD | 3.43% |
| 2018 Q1 | 8.8 Million USD | 3.5% |
| 2017 Q3 | 8.2 Million USD | 4.23% |
| 2017 Q1 | 7.56 Million USD | 3.76% |
| 2017 FY | 8.51 Million USD | 16.72% |
| 2017 Q4 | 8.51 Million USD | 3.71% |
| 2017 Q2 | 7.87 Million USD | 4.06% |
| 2016 Q1 | 6.43 Million USD | 4.52% |
| 2016 Q4 | 7.29 Million USD | 4.15% |
| 2016 Q3 | 7 Million USD | 4.23% |
| 2016 Q2 | 6.71 Million USD | 4.41% |
| 2016 FY | 7.29 Million USD | 18.48% |
| 2015 Q2 | 4.59 Million USD | -14.46% |
| 2015 Q1 | 5.36 Million USD | 5.26% |
| 2015 Q4 | 6.15 Million USD | 4.42% |
| 2015 FY | 6.15 Million USD | 20.71% |
| 2015 Q3 | 5.89 Million USD | 28.38% |
| 2014 Q1 | 4.34 Million USD | 5.89% |
| 2014 Q3 | 4.84 Million USD | 5.44% |
| 2014 Q4 | 5.09 Million USD | 5.32% |
| 2014 FY | 5.09 Million USD | 24.33% |
| 2014 Q2 | 4.59 Million USD | 5.73% |
| 2013 Q4 | 4.1 Million USD | 6.62% |
| 2013 FY | 4.1 Million USD | 29.54% |
| 2013 Q3 | 3.84 Million USD | 7.53% |
| 2013 Q2 | 3.57 Million USD | 7.5% |
| 2013 Q1 | 3.32 Million USD | 5.12% |
| 2012 Q1 | 2.54 Million USD | 6.8% |
| 2012 Q4 | 3.16 Million USD | 10.93% |
| 2012 FY | 3.16 Million USD | 32.73% |
| 2012 Q3 | 2.85 Million USD | 5.4% |
| 2012 Q2 | 2.7 Million USD | 6.3% |
| 2011 Q3 | 2.27 Million USD | -7.35% |
| 2011 Q4 | 2.38 Million USD | 4.69% |
| 2011 FY | 2.38 Million USD | 25.57% |
| 2011 Q1 | 2.11 Million USD | 11.36% |
| 2011 Q2 | 2.45 Million USD | 16.26% |
| 2010 Q1 | 1.1 Million USD | 21.22% |
| 2010 Q2 | 1.31 Million USD | 19.36% |
| 2010 Q4 | 1.89 Million USD | 21.8% |
| 2010 FY | 1.89 Million USD | 109.08% |
| 2010 Q3 | 1.55 Million USD | 18.65% |
| 2009 Q2 | 421.66 Thousand USD | 23.29% |
| 2009 Q4 | 908.4 Thousand USD | 89.03% |
| 2009 FY | 908.4 Thousand USD | 7.46% |
| 2009 Q1 | 342 Thousand USD | -59.54% |
| 2009 Q3 | 480.57 Thousand USD | 13.97% |
| 2008 Q2 | 2.03 Million USD | 0.0% |
| 2008 FY | 845.37 Thousand USD | -47.36% |
| 2008 Q1 | 2.03 Million USD | 26.74% |
| 2008 Q3 | 699.34 Thousand USD | -65.64% |
| 2008 Q4 | 845.37 Thousand USD | 20.88% |
| 2007 Q4 | 1.6 Million USD | -43.08% |
| 2007 Q3 | 2.82 Million USD | 594.91% |
| 2007 Q2 | 406.02 Thousand USD | -79.88% |
| 2007 Q1 | 2.01 Million USD | 5.4% |
| 2007 FY | 1.6 Million USD | -16.13% |
| 2006 Q2 | 2.72 Million USD | 14.33% |
| 2006 Q1 | 2.38 Million USD | 15.97% |
| 2006 FY | 1.91 Million USD | -6.92% |
| 2006 Q4 | 1.91 Million USD | -36.7% |
| 2006 Q3 | 3.02 Million USD | 10.9% |
| 2005 Q4 | 2.05 Million USD | 36.17% |
| 2005 Q1 | 719.14 Thousand USD | 23.06% |
| 2005 Q3 | 1.51 Million USD | 38.98% |
| 2005 FY | 2.05 Million USD | 252.01% |
| 2005 Q2 | 1.08 Million USD | 51.15% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 FY | 584.39 Thousand USD | 0.0% |
| 2004 Q4 | 584.39 Thousand USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -318.982% |
| Ansell Limited | 1.32 Billion USD | 99.26% |
| Ansell Limited | 1.33 Billion USD | 99.261% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 92.207% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -943.863% |
| Psykey, Inc. | 2.47 Million USD | -297.953% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.512% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.513% |
| Encision Inc. | 1.98 Million USD | -396.249% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -223.812% |
| Innovative MedTech Inc. | 6.13 Million USD | -60.484% |
| LifePoint, Inc. | 2.45 Million USD | -301.172% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 3.296% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -189.571% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -223.828% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -1168.203% |
| SmileDirectClub, Inc. | 982.26 Million USD | 98.998% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.274% |
| SheerVision, Inc. | 1.43 Million USD | -587.817% |
| United Health Products, Inc. | 1.99 Million USD | -392.55% |
| Vasamed, Inc. | 1 Million USD | -879.352% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -159.071% |
| Yubo International Biotech Limited | 2.91 Million USD | -237.875% |